12. Morris L. A., Mazis M. B., Brinberg D. Risk disclosures in televised prescription drug advertising to consumers.
13. Stevenson R. W. COMPANY NEWS; Glaxo offers $14 billion for Wellcome.
14. Corey L, Reeves W. C., Chiang WT, Vontver L. A., Remington M, Winter C, Holmes K. K. Ineffectiveness of topical ether for the treatment of genital herpes simplex virus infection.
15. Fleming D. T., McQuillan G. M., Johnson R. E., Nahmias A. J., Aral S. O., Lee F. K., St Louis M. E. Herpes simplex virus
16. US Preventive Services Task Force, Bibbins-Domingo K, Grossman D. C., Curry S. J., Davidson K. W., Epling J. W. Jr, Garcia F. A., Kemper A. R., Krist A. H., Kurth A. E., Landefeld C. S., Mangione C. M., Phillips W. R., Phipps M. G., Pignone M. P., Silverstein M, Tseng C. W. Serologic screening for genital herpes infection: U.S. Preventive Services Task Force recommendation statement.
17. Agyemang E, Le Q. A., Warren T, Magaret A. S., Selke S, Johnston C, Jerome K. R., Wald A. Performanceof commercial enzyme-linked immunoassays for diagnosis of herpes simplex virus-1 and herpes simplex virus-2 infection in a clinical setting.
18. Kaufman A. The STD that keeps most contestants from competing on “The Bachelor.”
19. Wald A. Hermeneutics of herpes: the American sexually transmitted diseases association distinguished career award lecture.
20. Mancuso R.